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Chemical Genetic Identification of the Histamine
H1 Receptor as a Stimulator
of Insulin-Induced Adipogenesis
ation of 3T3-L1 cells, thiazolidinediones, dexamethasone,
methylisobutylxanthine, HIV protease inhibitors, MAPK
inhibitors, nonsteroidal anti-inflammatory drugs, and
cyclosporin have been found to influence the differentia-
tion [5–9]. These adipogenesis modulators facilitated
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Here we analyze the effects of 880 bioactive small
molecules on the insulin-induced adipogenesis of 3T3-
L1 cells. The biological mechanisms or pharmacologicalSummary
effects of these molecules have been extensively stud-
ied, and many of them are marketed as pharmaceuticals.A large collection of bioactive compounds with diverse
Just as DNA microarray analysis with annotated genebiological effects can be used as probes to elucidate
probes has provided insights into novel gene functions,new biological mechanisms that influence a particular
the phenotypic adipogenesis assay with the annotatedcellular process. Here we analyze the effects of 880
chemical library may permit quick elucidation of newwell-known small-molecule bioactives or drugs on the
biological mechanisms that influence adipogenic differ-insulin-induced adipogenesis of 3T3-L1 fibroblasts, a
entiation.cell-culture model of fat cell differentiation. Our screen
identified 86 compounds as modulators of the adipo-
genic differentiation of 3T3-L1 cells. Examination of
Resultstheir chemical and pharmacological information re-
vealed that antihistamine drugs with distinct chemical
Effects of 880 Compounds on Adipogenesisscaffolds inhibit differentiation. Histamine H1 receptor
We assayed a collection of 880 bioactive compoundsis expressed in 3T3-L1 cells, and its knockdown by
for their ability to modulate the insulin-induced adipo-small interfering RNA impaired the insulin-induced ad-
genesis of 3T3-L1 cells. These commercially availableipogenic differentiation. Histamine receptors and his-
bioactives (average molecular weight  377) were se-tamine-like biogenic amines may play a role in induc-
lected for structural diversity and a broad spectruming adipogenesis in response to insulin.
covering therapeutic areas including neuropsychiatry,
cardiology, immunology, anti-inflammatory, analgesia,
Introduction cancer, metabolic diseases, etc. More than 85% of the
compounds have been marketed either in the United
The ongoing global explosion in the incidence of obesity States or Europe as pharmaceuticals or supplements,
has fueled efforts on molecular understanding of fat cell and their biological mechanisms or pharmacological
differentiation. The study of different steps leading to effects have been extensively studied. The results of
this terminal differentiation has been facilitated by the repeated phenotypic assays at 5 M showed that 47
development of established preadipocyte cell lines. compounds stimulated adipogenesis while 39 com-
Among them, the 3T3-L1 fibroblast cell line is perhaps pounds blocked differentiation without detectable cyto-
the best characterized, and its differentiation has served toxicity. Fifteen of 47 adipogenesis-enhancing chemi-
as an excellent cell-culture model of adipogenesis [1, 2]. cals were analogs of steroid hormones, consistent with
When treated with insulin, 3T3-L1 cells undergo differen- the reported adipogenic effects of the glucocorticoid
tiation to mature fat cells, which are morphologically family of steroids [3]. The adipogenesis-enhancing com-
distinct from the original cells because of their rounded pounds also included the Nachannel blockers, mexilet-
shapes and the presence of cytoplasmic oil droplets. The ine and amiodarone, and the anticoagulants, acenocu-
transparent morphology of 3T3-L1-derived adipocytes marol and dicumarol. On the other hand, the 39
has been used for unveiling the molecular events that adipogenesis-blockers included antibiotics, agricultural
orchestrate adipogenesis, including the roles of C/EBPs chemicals, and nucleotide analogs. Figure 1 shows typi-
and PPAR in mediating the expression of adipocyte- cal examples of morphological appearance and RT-PCR
specific genes [3, 4]. analysis of the chemical-treated cells. The cells treated
New biological pathways that influence particular cellu- with mifepristone (steroid), harmin (alkaloid), or homo-
lar processes are often discovered by the use of bioactive cystein thiolactone (amino acid analog) exhibited en-
small molecules. In the case of the adipogenic differenti- hanced adipogenesis and increased expression of the
adipogenic marker aP2. By contrast, the differentiation
of cells incubated with isotretinoin (retinoic acid analog),*Correspondence: muesugi@bcm.tmc.edu
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Figure 2. Inhibition of Adipogenic Differentiation by Histamine
Blockers
The differentiation of 3T3-L1 cells was induced by insulin in the
presence of 5M of histamine blockers: diphenhydramine (B), chlor-
pheniramine (C), astemizole (D), and triprolidine (E). Ten days after
the induction, the differentiated cells were stained with Oil-Red O,
and their microscopic images were captured. (A) shows a micro-
scopic image of the cells treated with 1% (v/v) DMSO only. The
Figure 1. Effects of 880 Bioactive Compounds on Insulin-Induced levels of differentiation were also evaluated by RT-PCR analysis of
Adipogenesis of 3T3-L1 Cells the aP2 gene, an adipocyte-specific marker (F).
The differentiation of 3T3-L1 cells was induced by insulin in the
presence of 1% (v/v) DMSO only (B) or 5 M compounds. Ten days While performing the adipogenesis assays, we noted
after the induction, the differentiated cells were stained with Oil-
persistent adipogenesis-blocking effects of histamineRed O, and their microscopic images were captured. Effects of
H1 receptor antagonists. Incubation with any one ofrepresentative adipogenesis enhancers and blockers are shown:
the four clinically used histamine H1 receptor blockers,mifepristone (C), harmin (D), homocystein thiolactone (E), isotreti-
noin (F), thioguanosine (G), and dequalinium (H). (A) shows a micro- diphenhydramine, chlorpheniramine, astemizole, and
scopic image of the cells without insulin induction. The levels of triprolidine completely abolished the differentiation of
differentiation were also evaluated by RT-PCR analysis of the aP2 3T3-L1 cells, resulting in no accumulation of triacylglyc-
gene, an adipocyte-specific marker (I). erol vesicles and impaired expression of the aP2 marker
(Figure 2). Chemically analogous monoamine drugs with
no antihistamine activity such as dacarbazine had little
thioguanosine (nucleotide analog), and dequalinium (an- effect on adipogenic differentiation (data not shown),
tibiotic) was completely abolished, showing no oil drop- suggesting that the inhibition of adipogenesis is due to
histamine antagonism.lets and no detectable increase of aP2 mRNA levels.
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Figure 4. Expression Levels of the Histamine H1 and H2 Receptors
in Undifferentiated and Fully Differentiated 3T3-L1 Cells
Total RNA was extracted from undifferentiated 3T3-L1 fibroblasts or
fully differentiated counterparts, and subjected to RT-PCR analysis
with primers specific for the histamine H1 receptor, the histamine
H2 receptor, aP2, and -actin. The histamine H1 receptor is ex-
pressed both in undifferentiated and differentiated 3T3-L1 cells,
while expression of histamine H2 receptor was detected only after
differentiation.
Expression of the Histamine H1 ReceptorFigure 3. Inhibition of Adipogenic Differentiation by an Anti-Hista-
mine Antibody in 3T3-L1 Cells
We next examined the expression levels of histamineThe differentiation of 3T3-L1 cells was induced by insulin in the
presence of anti-histamine or anti-serotonin antibodies. Ten days receptors in 3T3-L1 cells. Four members of the hista-
after the induction, the differentiated cells were stained with Oil- mine receptor family have been described so far (H1,
Red O and counted (A). Addition of free histamine to the medium H2, H3, and H4 receptors) [12, 13]. RT-PCR analysis of
in the presence of anti-histamine antibody restored the insulin-
each receptor gene demonstrated that the histamine H1induced adipogenesis, while that of serotonin had no detectable
receptor is highly expressed both in 3T3-L1 cells andeffect (B). Mean values and SE of three independent experiments
were plotted. their fully differentiated counterparts (Figure 4). Expres-
sion of the H2 receptor was detected only after differen-
tiation (Figure 4), and expression of the H3 and H4 recep-
tors was observed neither before nor after differentiationHistamine as an Adipogenic Factor
(data not shown). Diphenhydramine, chlorpheniramine,for 3T3-L1 Cells
astemizole, and triprolidine are well-known blockers se-Histamine, released from mast cells, basophils, or enter-
lective for histamine H1 receptor [12]: the expression ofochromaffin-like cells, circulates in the blood, with nor-
the H1 receptor in 3T3-L1 cells is consistent with themal mouse plasma containing a high nM range of hista-
observed inhibitory effects of H1-receptor-selective an-mine [10]. We quantified the histamine concentration in
tagonists.the fetal bovine serum that we used for the differentiation
of 3T3-L1 cells and found that it contained 14.1 nM
histamine, which is higher than the estimated Kd of hista- Knockdown of the Histamine H1 Receptor
mine for the histamine H1 receptor [11]. We speculated Impairs the Adipogenesis of 3T3-L1 Cells
that histamine in the fetal bovine serum acts as a stimu- It is possible to imagine that H1 antagonists inhibit adi-
latory factor for the adipogenic differentiation of 3T3- pogenesis by targeting proteins other than the histamine
L1 cells. To test this hypothesis, we used anti-histamine H1 receptor. For example, diphenhydramine, chlorphen-
antibody to neutralize histamine in the culture medium. iramine, and triprolidine have been reported to inhibit
3T3-L1 cells were treated with insulin in the presence cytochrome P-450 2D family members, as well as the
of anti-histamine antibody, and the numbers of differen- histamine H1 receptor (14). To gain direct evidence that
tiated cells were counted after staining with Oil-Red the histamine H1 receptor plays a role in inducing the
O. The neutralization of serum histamine resulted in a adipogenic differentiation of 3T3-L1 cells, we employed
decreased number of differentiated cells in a dose- the small interfering RNA (siRNA) technique [15]. An
dependent manner. In contrast, an anti-serotonin anti- oligonucleotide duplex encoding an siRNA specific for
body had no detectable effect on adipogenic differentia- the histamine H1 receptor was inserted into an expres-
tion even at high concentration (Figure 3A). Addition of sion vector driven by the RNA polymerase III H1 gene
free histamine back into the medium restored the level of promoter [16], and the resulting vector was stably trans-
adipogenesis, whereas adding serotonin had no effect fected into 3T3-L1 cells. Neomycin-resistance selection
(Figure 3B). These results suggest that histamine in the established two stably transfected clones. RT-PCR
analysis of the clones confirmed selective silencing ofserum potentiates the insulin-induced differentiation.
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histamine H1 receptor expression (Figure 5A). The
knockdown of the histamine H1 receptor rendered the
two clones resistant to insulin-induced adipogenesis
(Figures 5B–5H): no oil droplets or expression of the
aP2 gene was observed after insulin treatment, while
20%–30% cells of 3T3-L1 neo, a transformant with the
empty vector, differentiated just as well as the parental
3T3-L1 cells. These results indicate that the histamine
H1 receptor is required for the facile, efficient adipogen-
esis of 3T3-L1 cells.
Discussion
Histamine and Insulin
Histamine is a chemical mediator implicated in inflam-
mation, gastric acid secretion, and neurotransmission
[17–21] and its antagonists are excellent pharmaceuti-
cals for allergy and gastric ulcer [22, 23]. Our study
identified histamine blockers as inhibitors of the insulin-
induced differentiation of 3T3-L1 cells and suggested a
role for the histamine H1 receptor in promotion of insu-
lin-induced adipogenesis. Roles of histamine in food
intake and adiposity have been demonstrated using a
range of animal models. In whole animals, however,
disruption of the histamine H1 receptor generates obese
phenotypes instead of decreased levels of body fat [24].
The obese phenotypes are believed to result primarily
from disabled neuronal function of histamine and
thereby inhibition of leptin, a circulating satiety factor
that suppresses food intake [24, 25]. Phenotypes of
knockout animals are often governed by systemic,
global effects of gene function in the context of complex
interplay of related proteins: the adipogenic effects of
the histamine H1 receptor, which were detectable in
cultured cells, may be masked and undetectable in the
knockout mice. It is also possible that the adipogenic
effects of the histamine H1 receptor or histamine are
exerted transiently or under particular conditions in vivo
and might be pronounced only in the in vitro model of
adipogenesis.
Our results can also be explained by considering his-
tamine as a general stimulatory factor of insulin, as the
inhibition of histamine rendered 3T3-L1 cells completely
nonresponsive to insulin for adipogenesis. The stimula-
tory role of histamine is consistent with the glucose
intolerance and insulin resistance reported recently in
knockout mice of histidine decarboxylase, the rate-lim-
iting enzyme for histamine synthesis in mammals [26].
The blood glucose levels in these mice are not respon-
Figure 5. Inhibition of Insulin-Induced Adipogenesis by siRNA
sive to injected insulin, and symptoms of hyperinsulin- Knockdown of the Histamine H1 Receptor
emia have been observed. Moreover, it has recently 3T3-L1 cells were transfected with an expression vector encoding
been reported that histamine stimulates glucose uptake an siRNA specific for the histamine H1 receptor gene, and two stably
in rat adipocyte [27] and that insulin up-regulates ex- transfected clones were obtained. RT-PCR analysis of the clones
demonstrated the successful knockdown of the histamine H1 recep-pression of the histamine H1 receptor in human astrocy-
tor in both clones (A). When induced by insulin, approximately 20%toma cells [28]. These previous observations and ours
of 3T3-L1 neo cells exhibited phenotypes of adipocytes (B and C),all suggest that histamine and its receptors play a role
whereas the knockdown clones were resistant to insulin-induced
in controlling insulin function and its resistance. How- differentiation (D–G). The levels of differentiation were also evalu-
ever, it remains unclear how histamine modulates insulin ated by RT-PCR analysis of the aP2 gene, an adipocyte-specific
function. The insulin-induced differentiation of 3T3-L1 marker (H).
cells may find use as an in vitro phenotypic model for
understanding the potential role of histamine and its
receptors in further detail.
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Adipogenesis for Monitoring Histamine conditions. One needs to ensure that the phenotype
caused by a compound is indeed due solely to the inhibi-In our previous work, we profiled a chemical library of
10,000 divergent synthetic compounds, using the adipo- tion of its supposed target. Confirmation using indepen-
dent approaches is required after an initial chemicalgenic differentiation of 3T3-L1 cells. Differentiation pro-
filing enabled the construction of a smaller focused li- screening, and the siRNA technique may be an excellent
companion when a phenotype-causing probe inhibits abrary of bioactive molecules, from which we were able to
isolate small molecules with a range of pharmacological protein’s function. In our study, a correlation between
histamine-blocking activity and adipogenesis inhibitioneffects [29]. The results suggested that insulin-induced
adipogenesis serves as a phenotypic indicator of seem- was found in multiple compounds and served as a basis
for the successful siRNA analysis of the histamine H1ingly unrelated pharmacological effects of chemicals.
Here we profiled 880 “known” drugs by adipogenesis in receptor. Our results suggest that careful examination of
the structure-activity relationship of phenotype-causingsearch of therapeutically important signaling pathways
that modulate insulin-induced adipogenesis. The screen- probes relieves the specificity concern and leads to a
tractable number of hypotheses for more time-consum-ing results, followed by siRNA validation, show that his-
tamine blockers impair the differentiation of 3T3-L1 cells ing siRNA confirmation.
through their inhibition of the histamine H1 receptor.
The insulin-induced adipogenesis of 3T3-L1 cells may Significance
prove to be a convenient phenotypic assay for the analy-
sis of the histamine H1 receptor pathway or its chemical Systematic elucidation of protein function by small-
modulators. molecule probes is referred to as reverse chemical
genetics [36]. This interdisciplinary approach uniting
biology, chemistry, and pharmacology still has prob-
Use of an Annotated Chemical Library to Elucidate lems to overcome for its full potential to be reached,
Biological Functions but enriches future opportunities in biology and medi-
Bioactive small molecules, whether natural products or cine. Our case study, although at an early stage of
synthetic, have served as a powerful probe for the study the field, provides an encouraging example for the
of protein function in cells. Among prominent examples forthcoming endeavor and suggests an interesting
are the immunosuppressive drug FK506, the microtu- role for histamine receptors in insulin-induced adipo-
bule poison colchicine, the tumor promoter phorbol es- genesis.
ters, the histone-deacetylase inhibitor trichostatin A, the
kinase inhibitor wortmannin, and the proteasome inhibi- Experimental Procedures
tor lactacystin [30–33]. These probes have been exten-
Materialssively used for the biological studies by virtue of their
3T3-L1 cells were obtained from ATCC and maintained in DMEMconvenient handling, high cell permeability, and condi-
supplemented with 10% calf serum. Anti-histamine or serotonin
tional nature of their chemical effects. A large collection antibodies were from CHEMICON and ImmunoStar, respectively. A
of such biologically proven compounds would constitute collection of 880 bioactive compounds (Prestwick Chemical Library)
a library of annotated chemical probes that could permit was purchased from Prestwick Chemical. Twenty-five milligrams of
dry powder of each compound were dissolved in DMSO and storedquick elucidation of new biological mechanisms [34].
in dark at 20 C before use.Our case study supports the proposed utility of large
libraries of annotated chemical probes for biological
Chemical Screen of the Adipogenic Differentiationstudies. However, the chemical library used in this study
3T3-L1 cells were grown to complete confluence and incubated for
is still insufficient in its number and diversity: it consists another two days. The medium was switched to DMEM containing
primarily of off-patent drugs and widely known bioac- 10% fetal bovine serum, 5 g/ml of insulin, and 5 M of each bioac-
tives. Fortunately, recent advances in chemical diversity tive compound. The final DMSO concentration was 1% (v/v). Three
days after the induction of adipogenic differentiation, half of thegeneration and new screening methodologies are in-
medium was changed to fresh medium without chemicals every twocreasing the number of unique bioactive compounds
days. Adipose oil droplets were stained with Oil-Red O ten dayswith novel mechanisms [35]. Once the newly discovered
after the chemical treatment, and the cells were examined under
agents have been more completely studied through fur- microscope. This procedure permits the adipogenesis of 15%–20%
ther selectivity validation or target identification, they of the cells in the absence of a chemical (DMSO control), enabling
will supplement the array of biologically active mole- the discovery of both adipogenesis enhancers and blockers.
cules that are currently available and might constitute
RT-PCRa chemical library that can probe a more complete set
Total RNA extraction and reverse transcription reaction were per-of gene products and pathways. Target identification
formed as described [28]. Primer sets used for PCR were as follows.of bioactive compounds, whether synthetic or natural
The histamine H1 receptor: 5-CTG GTG GTG GTT CTT AGT AGT
products, will increasingly be important for future en- ATC-3 (sense) and 5-CAG CAT CAG CAA AGT GGG GAG GTA-3
deavors because newly discovered agents can never (antisense). The histamine H2 receptor: 5-CGT CTG CCT GGC TGT
CAG CTT G-3 (sense) and 5-AGA GGC AGG TAG AAG GTG ACCbe useful for the type of applications described here
A-3 (antisense). The histamine H3 receptor: 5-CTC TGC AAG CTGuntil they have been annotated.
TGG CTG GTG GTA GAC TAC CTA CTG TGT G-3 (sense) and 5-The greatest challenge of the chemical approach re-
CTT CTT GTC CCG CGA CAG CCG AAA GCG CTG GGT GAT GCTmains the issue of specificity. A number of excellent
T-3 (antisense). The histamine H4 receptor: 5-CAC GCT GTT TAA
small-molecule drugs, especially synthetic ones, target CTG GAA TTT TGG AAG TGG AAT CTG CAT G-3 (sense) and 5-
multiple cellular proteins to achieve synergistic pharma- ACC AAG AAA GCC AGT ATC CAA ACA GCC ACC ATT TGA GC-3
(antisense). Beta-actin: 5-CGT ACC ACC GGC ATT GTG AT-3cological effects and to allow application in broader
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(sense) and 5-GAG CAG TAA TCT CCT TCT GC-3 (antisense). The activated T cells family of transcriptional regulatory proteins in
adipogenesis. Proc. Natl. Acad. Sci. USA 95, 15537–15541.primers for the aP2 gene were described in our previous study [29].
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lian cells. Science 296, 550–553.two stable transformants were established. The expression levels
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